Profil Financier
Habil Khorakiwala occupe actuellement le rang #2355 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.8 B (-$243 sur 24h).
Pharma tycoon Habil Khorakiwala chairs Wockhardt, one of India's top makers of generic drugs.
He founded Wockhardt in 1967 after breaking away from his family's storied retailing empire.
His son Murtaza runs the Mumbai company which counts the U.K. as one of its top markets.
His daughter Zahabiya oversees the hospital arm while another son heads the charitable foundation.
Khorakiwala has served as the honorary consul general of Sweden in India.